Search
At present, limited literature exists exploring patient preferences for prophylactic treatment of acute rheumatic fever and rheumatic heart disease. Given low treatment completion rates to this treatment in Australia, where the burden of disease predominantly affects Aboriginal and Torres Strait Islander people, an improved understanding of factors driving patient preference is required to improve outcomes.
Congratulations to Alec Truswell, Tamara Veselinović, Anastasia Phillips, and Wenna Lee for being awarded Seed Funding through the Wesfarmers Centre of Vaccines & Infectious Diseases, each valued at up to $25,000, and to Sonia McAlister, the recipient of the 2026 Riley Hughes Memorial Award in Pertussis Research.
Innovative research aiming to prevent the spread of Strep A using ‘friendly’ bacteria in the throat has received a $1.5 million boost in the latest round of National Health and Medical Research Council grants.
At the Wesfarmers Centre, we undertake research in five key areas of infections and immunisation to assist in children's health.
Researchers from The Kids Research Institute Australia would like to understand more about respiratory syncytial virus (RSV) and how we can provide the best protection for kids.
Review the hospital-based research that the Wesfamers Centre of Vaccines & Infectious Diseases conducts.
We are evaluating new vaccines for a range of diseases including influenza, pneumococcal, meningococcal and common infections such as otitis media (glue ear).
Vaccine Trials Group with Sir Charles Gairdner Hospital is conducting a trial of a vaccine against Clostridium difficile infection (CDI) in at-risk individuals.
The study aims to determine whether an RSV vaccine given to pregnant women during the third trimester can protect newborn babies from RSV infections.
Through co-design with community members, we hope to better understand the strengths and effectiveness of community-driven health promotion resources.